Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jubilant Ingrevia's Other Operating Expense for the
three
months ended in Jun. 2026 was ₹5,121 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was ₹17,621 Mil.
Jubilant Ingrevia's quarterly Other Operating Expense
increased
from Dec. 2025 (₹4,022 Mil) to Mar. 2026 (₹4,331 Mil) and
increased
from Mar. 2026 (₹4,331 Mil) to Jun. 2026 (₹5,121 Mil).
Jubilant Ingrevia's annual Other Operating Expense
declined
from Mar. 2024 (₹14,651 Mil) to Mar. 2025 (₹14,528 Mil) and
declined
from Mar. 2025 (₹14,528 Mil) to Mar. 2026 (₹14,438 Mil).
Jubilant Ingrevia Other Operating Expense Related Terms
Jubilant Ingrevia Other Operating Expense Historical Data
* Premium members only.
The historical data trend for Jubilant Ingrevia's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹17,621 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of ₹17,621 Mil mean?
Jubilant Ingrevia (BOM:543271) has a Other Operating Expense of ₹17,621 Mil as of Jun. 2026. Other operating expenses that a company records on its income statement. View historical data on Jubilant Ingrevia and its competitors.
Is Jubilant Ingrevia's Other Operating Expense too high?
Jubilant Ingrevia's current Other Operating Expense is ₹17,621 Mil. Overall, Jubilant Ingrevia has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jubilant Ingrevia's Other Operating Expense compare to LIN and SHW?
Jubilant Ingrevia's Other Operating Expense of ₹17,621 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Chemicals company?
A good Other Operating Expense depends on the Chemicals industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Jubilant Ingrevia and its competitors. Jubilant Ingrevia's current Other Operating Expense is ₹17,621 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jubilant Ingrevia stock overvalued right now?
Based on GuruFocus' analysis, Jubilant Ingrevia (BOM:543271) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹761.49, compared to a current price of ₹675.25 — trading 11.3% below its estimated fair value. The current Other Operating Expense is ₹17,621 Mil. Jubilant Ingrevia's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Jubilant Ingrevia (BOM:543271), the current Other Operating Expense is ₹17,621 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jubilant Ingrevia (BOM:543271) Overvalued in 2026?
Based on GuruFocus' analysis, Jubilant Ingrevia stock appears to be undervalued.
The current stock price of ₹675.25 is trading 11.3% below its estimated GF Value™ of ₹761.49.
GuruFocus considers Jubilant Ingrevia to be Modestly Undervalued.
Key valuation signals for BOM:543271:
Other Operating Expense: ₹17,621 Mil
GF Value™: ₹761.49 vs. price of ₹675.25 (11.3% below fair value)
No single metric tells the full story. See the BOM:543271 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jubilant Ingrevia Ltd is a life science products and solutions provider in the chemicals industry. It serves Pharmaceutical, Nutrition, Agrochemical, Consumer, and Industrial customers with its customized products and solutions. Its segments are Specialty chemicals, Nutrition & Health solutions, and Chemical Intermediates. The maximum revenue for the company is generated from its Specialty chemicals segment, which includes Bio-Pyridine & Bio-Picolines, Fine chemicals, Agro chemicals, Custom development and manufacturing organization, Microbial control solutions.. Geographically, it derives key revenue from India and the rest from the Americas and Europe, China, and the Rest of the world.
82GF Score
Get the complete analysis for BOM:543271
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543271 has been successfully added to your 
